162 related articles for article (PubMed ID: 29605055)
1. Disparities in genetics assessment for women with ovarian cancer: Can we do better?
Manrriquez E; Chapman JS; Mak J; Blanco AM; Chen LM
Gynecol Oncol; 2018 Apr; 149(1):84-88. PubMed ID: 29605055
[TBL] [Abstract][Full Text] [Related]
2. Germline BRCA Mutation Rates in Latina Women Presenting for Gynecologic Oncology Care.
Hong L; Gonzalez R; Unternaehrer J; Ioffe Y
Gynecol Obstet Invest; 2020; 85(3):214-221. PubMed ID: 32203957
[TBL] [Abstract][Full Text] [Related]
3. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
[No Abstract] [Full Text] [Related]
4.
Piedimonte S; Power J; Foulkes WD; Weber E; Palma L; Schiavi A; Ambrosio E; Konci R; Gilbert L; Jardon K; Baret L; Zeng X
Int J Gynecol Cancer; 2020 Nov; 30(11):1757-1761. PubMed ID: 32759180
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Armstrong K; Micco E; Carney A; Stopfer J; Putt M
JAMA; 2005 Apr; 293(14):1729-36. PubMed ID: 15827311
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
[TBL] [Abstract][Full Text] [Related]
7. Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
Boitano TKL; Barrington DA; Batra S; McGwin G; Turner TB; Farmer MB; Brown AM; Straughn MJ; Leath CA
Gynecol Oncol; 2019 Aug; 154(2):379-382. PubMed ID: 31196574
[TBL] [Abstract][Full Text] [Related]
8. Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.
Mallen AR; Conley CC; Townsend MK; Wells A; Boac BM; Todd S; Gandhi A; Kuznicki M; Augusto BM; McIntyre M; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
Clin Genet; 2020 Feb; 97(2):370-375. PubMed ID: 31600840
[TBL] [Abstract][Full Text] [Related]
9. Genetic counseling referral for ovarian cancer patients: a call to action.
Garcia C; Harrison K; Ring KL; Sullivan MW; Rauh LA; Modesitt SC
Fam Cancer; 2019 Jul; 18(3):303-309. PubMed ID: 30993488
[TBL] [Abstract][Full Text] [Related]
10. Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Armel SR; Volenik A; Demsky R; Malcolmson J; Maganti M; McCuaig J
Gynecol Oncol; 2020 Aug; 158(2):440-445. PubMed ID: 32505554
[TBL] [Abstract][Full Text] [Related]
11. Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system.
McCuaig JM; Care M; Ferguson SE; Kim RH; Stockley TL; Metcalfe KA
Gynecol Oncol; 2020 Sep; 158(3):747-753. PubMed ID: 32674931
[TBL] [Abstract][Full Text] [Related]
12. Disparities in care among patients with low-grade serous ovarian carcinoma.
Siemon J; Galli J; Slomovitz B; Schlumbrecht M
Gynecol Oncol; 2020 Apr; 157(1):46-54. PubMed ID: 32008792
[TBL] [Abstract][Full Text] [Related]
13. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Cragun D; Weidner A; Lewis C; Bonner D; Kim J; Vadaparampil ST; Pal T
Cancer; 2017 Jul; 123(13):2497-2505. PubMed ID: 28182268
[TBL] [Abstract][Full Text] [Related]
15. Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Lin J; Sharaf RN; Saganty R; Ahsan D; Feit J; Khoury A; Bergeron H; Chapman-Davis E; Cantillo E; Holcomb K; Blank SV; Liu Y; Thomas C; Christos PJ; Wright DN; Lipkin S; Offit K; Frey MK
Gynecol Oncol; 2021 Aug; 162(2):506-516. PubMed ID: 34023131
[TBL] [Abstract][Full Text] [Related]
16. Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status.
Bristow RE; Chang J; Ziogas A; Anton-Culver H; Vieira VM
Gynecol Oncol; 2014 Jul; 134(1):60-7. PubMed ID: 24680770
[TBL] [Abstract][Full Text] [Related]
17. Disparities in treatment and survival among elderly ovarian cancer patients.
Taylor JS; He W; Harrison R; Zhao H; Sun CC; Lu KH; Giordano SH; Meyer LA
Gynecol Oncol; 2018 Nov; 151(2):269-274. PubMed ID: 30253875
[TBL] [Abstract][Full Text] [Related]
18. Referral patterns for genetic counselling of women diagnosed with tubo-ovarian or peritoneal high-grade serous carcinoma (HGSC) within the Auckland Gynaecological Oncology Centre.
Burling MJ; Gamet K; Eva L; Tan AL
Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):444-449. PubMed ID: 30883681
[TBL] [Abstract][Full Text] [Related]
19. Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States.
Austin S; Martin MY; Kim Y; Funkhouser EM; Partridge EE; Pisu M
Health Serv Res; 2013 Jun; 48(3):1135-53. PubMed ID: 23206237
[TBL] [Abstract][Full Text] [Related]
20. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A
Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
